Latest Michael J. Fox Foundation Stories
NEW YORK, April 15, 2015 /PRNewswire-USNewswire/ -- John Hardy, PhD, a pioneer in the study of Parkinson's genetics, is the recipient of the 2015 Robert A.
PPMI now recruiting individuals with genetic mutation linked to Gaucher disease NEW YORK, March 24, 2015 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI),
Baseline paper highlights findings from Fox Trial Finder, first smart-matching clinical research recruitment tool for Parkinson's disease NEW YORK, Feb.
REHOVOT, Israel, October 29, 2014 /PRNewswire/ -- Company also reports encouraging partial results from Phase IIa study of continuous, subcutaneously delivered high-dose
NEW YORK, Aug. 12, 2014 /PRNewswire-USNewswire/ -- Research projects from five groups active in Parkinson's research comprise the 2014 first half (1H 2014) of The Michael J.
NEW YORK, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease.
AFFiRiS AG presents Phase I data on a first-of-its-kind treatment with support from The Michael J.
VIENNA, July 29, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or
ATLANTA, July 28, 2014 /PRNewswire-USNewswire/ -- RaceTrac announced that its cumulative giving to The Michael J. Fox Foundation for Parkinson's Research has exceeded $1 million.
VIENNA, July 24, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or